Exploring predictors of mesh exposure after vaginal prolapse repair

Female Pelvic Medicine and Reconstructive Surgery

Volumn 19, Issue 4, 2013, Pages 206-209

  Sirls, Larry T ^a   McLennan, Gregory P ^b   Killinger, Kim A ^b   Boura, Judith A ^a   Fischer, Melissa ^a   Nagaraju, Pradeep ^a   Peters, Kenneth ^a  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Mesh exposure; Prolapse; Risk factors; Vaginal mesh repair

Indexed keywords

HEMOGLOBIN; REGRESSION ANALYSIS;

CATEGORICAL VARIABLES; CONTINUOUS VARIABLES; LOGISTIC REGRESSION ANALYSIS; MESH EXPOSURE; MESH REPAIR; PROLAPSE; RISK FACTORS; WILCOXON RANK TESTS;

REPAIR;

HEMOGLOBIN; MORPHINE; STEROID;

ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MESH SLING; OPERATION DURATION; PELVIC ORGAN PROLAPSE; POSTOPERATIVE PAIN; RETROSPECTIVE STUDY; SMOKING; TOBACCO USE; VAGINA RECONSTRUCTION; VAGINAL SUPPORT DEVICE; AGED; CLINICAL COMPETENCE; CLINICAL PRACTICE; METABOLISM; MIDDLE AGED; PATIENT SELECTION; RECURRENT DISEASE; RISK FACTOR; SURGICAL MESH; UTERUS PROLAPSE; UTILIZATION REVIEW;

AGED; BODY MASS INDEX; CLINICAL COMPETENCE; FEMALE; HEMOGLOBINS; HUMANS; MIDDLE AGED; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL MESH; UTERINE PROLAPSE;

EID: 84883004140     PISSN: 21518378     EISSN: 21544212     Source Type: Journal    
DOI: 10.1097/SPV.0b013e318298b381     Document Type: Article

References (12)

1. Carey MH, Higgs P, Goh J. Vaginal repair with mesh versus colporrhaphy for prolapse: a randomized controlled trial. Br J Obstet Gynecol 2009;116(10):1380-1386.
2. Maher C, Feiner B, Baessler K, et al. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2010;4:CD004014.
3. Altman D, Vayrynen T, Engh ME. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Eng J Med 2011;364(19):1826-1836.
4. United States Food and Drug Administration: FDA safety communication: Update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. [FDAWebsite]. July 13, 2011. Available at: http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm262435.htm. Accessed January 10, 2012.
5. Cundiff GW, Varner E, Visco AG. Risk factors for mesh/suture erosion following sacrocolpopexy. Am J Obstet Gynecol 2008;199(6):688 e1-688 e5.
6. Abed H, Rahn DD, Lowenstein L, et al.; for the Systematic Review Group of the Society of Gynecologic Surgeons. Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J 2011;22:789-798.
7. Kaufman Y, Singh SS, Alturki H, et al. Age and sexual activity are risk factors for mesh exposure following transvaginal mesh repair. Int Urogynecol J 2011;22(3):307-313.
8. Vaiyapuri GR, Han HC, Lee LC, et al. Use of the Gynecare Prolift system in surgery for pelvic organ prolapse: 1 year outcome. Int Urogynecol J 2011;22:869-877.
9. Haylen BT, Freeman RM, Swift SE, et al. An International Urogynecological Association/International Continence Society joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Int Urogynecol J 2011;22:3-15.
10. Gammaitoni AR, Fine P, Alvarez N, et al. Clinical application of opioid equianalgesis data. Clin J Pain 2003;19(5):286-297.
11. Biswas N, Hogston P. Surgical risk from obesity in gynaecology. The Obstetrician and Gynecologist 2011;13:87-91.
12. Bako A, Dhar R. Review of synthetic mesh-related complications in pelvic floor reconstructive surgery. Int Urogynecol J 2009;20:103-111.